The Supreme Court’s move to strike down a petition seeking uniform menstrual leave in the country, saying a national-level ...
Conversations around the Cicada variant are gaining momentum as people question its origin and possible effects. While ...
In a landmark ruling, India’s top court orders a compensation framework for victims of rare but potentially deadly side ...
The war in the Middle East so far has not appreciably disrupted pharmaceutical supply chains, but the conflict could do so as ...
Despite the study missing its primary endpoint, Pfizer will continue with the regulatory submission of the vaccine.
5dOpinion
Generic versions of weight-loss drugs are a bulky opportunity for Chinese and Indian drugmakers
The simultaneous patent expiry of Ozempic in China and India has seen generic makers jump in. Low cost production in high ...
Indian students are increasingly seeking study abroad options beyond the US, UK, Canada, and Australia. New visa policies and ...
Discover how the once-revered Nifty Fifty stocks turned into dangerous investments, revealing the pitfalls of inflated market ...
In this week’s edition of InnovationRx, we look at a serial entrepreneur’s effort to build an FDA-approved AI doctor, ...
Even if the weight-loss drugs are a game changer, they are not a silver bullet to tackle the obesity problem in China and ...
‘We were told it was safe’: Inside the legal battle over Covid vaccine deaths in India - IN FOCUS: In a landmark ruling, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results